We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$54B
AUM Growth
-$3.2B
Cap. Flow
-$865M
Cap. Flow %
-1.6%
Top 10 Hldgs %
28.71%
Holding
986
New
116
Increased
314
Reduced
359
Closed
149

Top Buys

Rank Stock Value
1
HUBB icon
Hubbell
HUBB
+$244M
2
NSC icon
Norfolk Southern
NSC
+$149M
3
INSM icon
Insmed
INSM
+$138M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131M
5
DHR icon
Danaher
DHR
+$119M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$340M
2
BMY icon
Bristol-Myers Squibb
BMY
+$339M
3
UNP icon
Union Pacific
UNP
+$191M
4
MCD icon
McDonald's
MCD
+$190M
5
HES
Hess
HES
+$168M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Healthcare 14.99%
3 Financials 12.56%
4 Consumer Discretionary 9.54%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRT icon
951
Vertiv
VRT
$106B
-136,474
Closed -$15.5M
XYL icon
952
Xylem
XYL
$28.2B
-310,444
Closed -$36M
YUMC icon
953
Yum China
YUMC
$16.5B
-198,700
Closed -$9.57M
ZURA icon
954
Zura Bio
ZURA
$542M
-300,000
Closed -$750K
CTNM
955
Contineum Therapeutics
CTNM
$577M
-200,000
Closed -$2.93M
PACS icon
956
PACS Group
PACS
$7.39B
-10,000
Closed -$131K
CNR
957
Core Natural Resources Inc
CNR
$4.47B
-45,000
Closed -$4.8M
TLN
958
Talen Energy Corp
TLN
$16.2B
-65,000
Closed -$13.1M
ATYR
959
aTyr Pharma
ATYR
$49.2M
-1,000,000
Closed -$3.62M
QXO
960
QXO Inc
QXO
$16.4B
-50,148
Closed -$797K
LINE
961
Lineage Inc
LINE
$9.25B
-175,000
Closed -$10.2M
ORKA
962
Oruka Therapeutics
ORKA
$5.94B
-69,200
Closed -$1.34M
CBLL
963
CeriBell Inc
CBLL
$692M
-318,072
Closed -$8.23M
INGM
964
Ingram Micro Holding
INGM
$6.59B
-325,000
Closed -$6.3M
SEPN
965
Septerna Inc
SEPN
$1.78B
-300,000
Closed -$6.87M
DYNCU
966
Dynamix Corp Unit
DYNCU
-1,350,000
Closed -$13.4M
TTAN
967
ServiceTitan Inc
TTAN
$8.17B
-15,000
Closed -$1.54M
NPKI
968
NPK International
NPKI
$1.15B
-25,000
Closed -$192K
BECN
969
DELISTED
Beacon Roofing Supply, Inc.
BECN
-110,111
Closed -$11.2M
ALTR
970
DELISTED
Altair Engineering Inc
ALTR
-100,659
Closed -$11M
EDR
971
DELISTED
Endeavor Group Holdings, Inc.
EDR
-1,006,992
Closed -$31.5M
AZPN
972
DELISTED
Aspen Technology Inc
AZPN
-66,430
Closed -$16.6M
ALTM
973
DELISTED
Arcadium Lithium plc
ALTM
-8,340,634
Closed -$42.8M
NKGNW
974
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
-159,266
Closed -$15.9K
INFN
975
DELISTED
Infinera Corporation Common Stock
INFN
-4,124,512
Closed -$27.1M

Similar funds

Adage Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adage Capital Partners held 986 positions worth $54B, down 5.6% from $57.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners's Q1 2025 filing shows 116 new, 314 increased, 359 reduced and 149 closed positions. Its largest new stake was Diamondback Energy: 485,503 shares worth $77.6M. The largest sale was Royalty Pharma, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2025 buy was Diamondback Energy: 485,503 shares worth $77.6M.
  • Adage Capital Partners added most to Hubbell in Q1 2025, an estimated $244M increase.
  • Adage Capital Partners's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $340M.
  • Adage Capital Partners fully exited Geron in Q1 2025, selling an estimated $77.2M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $54B portfolio in Q1 2025.
  • Adage Capital Partners opened 116 new positions and closed 149 in Q1 2025.
  • Adage Capital Partners's portfolio value fell 5.6% quarter-over-quarter to $54B.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.